Athens-Limestone Hospital is is expanding its sleep treatment options with the addition of a therapy that can serve as an alternative to CPAP devices for moderate to severe sleep apnea […] ...

Dr. Bobby Simpson of Infirmary Health joined WKRG News 5 on The Doctor Is In to discuss sleep apnea and how it affects the ...

But for millions of people, the hours don't matter, because what's happening during those hours is closer to suffocation than ...

Sleep apnea becomes substantially more severe on weekends compared to weekdays, and the effect is amplified in people who ...

All of the ordinary shares are being offered by Nyxoah and there are no selling shareholders participating in the offering.

More Than Sleepless NightsObstructive sleep apnea (OSA) is often recognized for its impact on sleep quality and ...

Vivos Therapeutics, Inc. (“Vivos” or the “Company’’) (NASDAQ: VVOS), a leading medical device and healthcare services company focused on the treatment of breathing-related sleep disorders and ...

Commentary: Sleep apnea goes undiagnosed all too often, especially in women. The outmoded assumption is it mainly afflicts ...

If you're writing these symptoms off as stress, it might be time to look closer: Chronic daytime fatigue (despite 8 hours of ...

ResMed (RMD) outlines growth catalysts in sleep & breathing health: AI, wearables, GLP-1 tailwinds, COPD, and Noctrix RLS deal—read key takeaways now.

BofA Securities is acting as the lead bookrunner for the offering. Bank Degroof Petercam SA/NV is acting as an additional bookrunner and B. Riley is acting as a co-manager for the offering.

Eli Lilly just released impressive study results for retatrutide, an investigational weight loss drug that targets three ...